// App-Quantinova.ai

TH-OR02 : Roxadustat for the Treatment of Anemia in CKD Patients Not on Dialysis (NDD): A Phase 3, Randomized, Open-Label, Active-Controlled Study

Researchers

Presenter

  • Barratt Jonathan

Principal Investigators

  • Andric Branislav

  • Tataradze Avtandil

  • Schoemig Michael

  • Reusch Michael

  • Valluri Udaya

  • Mariat ChristopherR

Medical Centers

  • University of Leicester, Leicester, Leicestershire, United Kingdom

  • Health Center Krusevac Kruševac Serbia

  • National Center of Urology, Tbilisi, Georgia

  • Center of Dialysis and Nephrology Heilbronn and Neckarsulm Germany

  • Astellas Pharma Europe, Leiden, Netherlands

  • CHU St Etienne Service Nephrologie Dialyse Transplantation St Etienne France

Locations

  • United Kingdom

  • Serbia

  • Georgia

  • Germany

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hypertension

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • roxadustat

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Non Inferiority

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved